The clinical spectrum of pulmonary thromboembolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A European case series

•Pulnonary thromboembolism (PTE) is a frequent life-threatening complication in patients with COVID-19.•The onset of PTE varies from 2 to 4 weeks after the occurrence of the initial symptoms.•PTE may occur in patients without past history of risk factors for venous thromboembolism and in those receiving standard prophylactic anticoagulation.•Intermediate therapeutic dose of anticoagulants and extend thromboprophylaxis are necessary in these patients after meticulous risk-benefit assessment.